Stay updated on ORION-01 Oregovomab & Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.

Latest updates to the ORION-01 Oregovomab & Nivolumab Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision number changed from v3.7.1 to v3.7.2 on the error page.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the expected study information with an access notice. This indicates a site access issue rather than content updates.SummaryDifference20%

- Check54 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, signaling the latest version of the page. This is a metadata/version update rather than a substantive modification to study content or user-facing information.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now shows revision: v3.6.5 instead of v3.6.4, signaling a new release build. This appears to be a maintenance update that does not change study details or functionality.SummaryDifference0.1%

- Check90 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a minor metadata update to the page. It appears to be a versioning change rather than a substantive content update.SummaryDifference0.1%

Stay in the know with updates to ORION-01 Oregovomab & Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.